ストックスクリーナーアプリを入手
5.105
12.88%
-0.755
アフターアワーズ：
5.09
-0.015
-0.29%
前日終値:
$5.86
開ける：
$5.44
24時間の取引高:
2.40M
Relative Volume:
2.85
時価総額：
$280.24M
収益：
$124.00K
当期純損益:
$-49.99M
株価収益率:
-3.0207
EPS:
-1.69
ネットキャッシュフロー:
$-31.03M
1週間 パフォーマンス:
-13.62%
1か月 パフォーマンス:
-18.84%
6か月 パフォーマンス:
-35.46%
1年 パフォーマンス:
-19.10%
1日の値動き範囲:
$4.8619
$5.569
1週間の範囲:
$4.8619
$6.16
52週間の値動き範囲:
$3.785
$14.60
Candel Therapeutics Inc Stock (CADL) Company Profile
CADL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CADL
Candel Therapeutics Inc
|
5.105 | 317.84M | 124.00K | -49.99M | -31.03M | -1.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.23 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
722.01 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.26 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Candel Therapeutics Inc Stock (CADL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-30 | 再開されました | H.C. Wainwright | Buy |
| 2025-02-20 | 開始されました | Citigroup | Buy |
| 2025-02-19 | 開始されました | Canaccord Genuity | Buy |
| 2025-02-07 | 開始されました | BofA Securities | Buy |
| 2022-12-02 | 開始されました | H.C. Wainwright | Buy |
| 2021-11-19 | 開始されました | BMO Capital Markets | Outperform |
| 2021-08-23 | 開始されました | Credit Suisse | Outperform |
| 2021-08-23 | 開始されました | Jefferies | Buy |
| 2021-08-23 | 開始されました | UBS | Buy |
すべてを表示
Candel Therapeutics Inc (CADL) 最新ニュース
Candel Therapeutics Falls After Downgrade From BofA Securities - MarketScreener
Erasca, Candle, Xencor drop as BofA downgrades (ERAS:NASDAQ) - Seeking Alpha
Pattern recognition hints at Candel Therapeutics Inc. upside - Newser
Price action breakdown for Candel Therapeutics Inc.July 2025 Selloffs & Precise Swing Trade Alerts - Newser
What momentum shifts mean for Candel Therapeutics Inc.July 2025 Weekly Recap & Trade Opportunity Analysis - Newser
BofA Securities Downgrades Candel Therapeutics to Neutral From Buy - MarketScreener
Multi asset correlation models including Candel Therapeutics Inc.2025 Market Trends & Safe Swing Trade Setups - Newser
Chart based analysis of Candel Therapeutics Inc. trends2025 Analyst Calls & Capital Protection Trading Alerts - Newser
How to track smart money flows in Candel Therapeutics Inc.2025 Technical Patterns & Safe Entry Momentum Stock Tips - Newser
What does recent volatility data suggest for Candel Therapeutics Inc.Recession Risk & Fast Moving Stock Watchlists - Newser
How high can Candel Therapeutics Inc. stock goWeekly Profit Recap & Pattern Based Trade Signal System - Newser
How hedge fund analytics apply to Candel Therapeutics Inc. stockJuly 2025 Opening Moves & Consistent Income Trade Ideas - Newser
Candel Therapeutics shares rise 1.71% after-hours after appointing renowned immunotherapy expert Carl H. June to its Research Advisory Board. - AInvest
Rally Mode: Is Candel Therapeutics Inc. forming bullish engulfing patternsJuly 2025 Macro Moves & AI Powered Market Entry Strategies - khodrobank.com
Small Cap Stocks Gain Traction: MustGrow Biologics, Ocean Power Technologies, Medicus Pharma, Candel Therapeutics, Digi Power X, and G Mining Ventures Lead the Way - AInvest
Candel Therapeutics Inc. stock daily chart insightsMarket Activity Summary & Breakout Confirmation Alerts - Newser
Candel Therapeutics Appoints Renowned Immunotherapy Pioneer Carl H. June, M.D., to Research Advisory Board - The Manila Times
FDA-Approved CAR-T Pioneer Carl June Joins Candel Therapeutics to Guide Cancer Immunotherapy Development - Stock Titan
Live market analysis of Candel Therapeutics Inc.July 2025 Selloffs & Weekly Watchlist for Consistent Profits - Newser
Will Candel Therapeutics Inc. face regulatory challengesJuly 2025 Short Interest & Stepwise Trade Execution Plans - khodrobank.com
Published on: 2025-09-02 07:27:55 - beatles.ru
Using data models to predict Candel Therapeutics Inc. stock movement2025 Trade Ideas & High Win Rate Trade Tips - Newser
Is Candel Therapeutics Inc. a play on infrastructure spendingJuly 2025 Breakouts & Real-Time Volume Spike Alerts - khodrobank.com
Is Candel Therapeutics Inc. stock entering bullish territory2025 Dividend Review & Technical Buy Zone Confirmation - Newser
Can Candel Therapeutics Inc. expand its profit margins2025 Investor Takeaways & Low Drawdown Momentum Trade Ideas - khodrobank.com
Advanced analytics toolkit walkthrough for Candel Therapeutics Inc.2025 Trading Recap & Daily Entry Point Trade Alerts - Newser
Multi asset correlation models including Candel Therapeutics IncJuly 2025 Weekly Recap & Community Supported Trade Ideas - Newser
What indicators show strength in Candel Therapeutics Inc.Weekly Trend Report & Verified Technical Trade Signals - Newser
Trend Dashboard Flags Candel Therapeutics Inc. As Potential Swing TradeJuly 2025 Movers & Long-Term Capital Growth Strategies - beatles.ru
Will Candel Therapeutics Inc. benefit from macro trendsJuly 2025 Short Interest & AI Optimized Trading Strategy Guides - Newser
Candel Therapeutics Inc (CADL) 財務データ
収益
当期純利益
現金流量
EPS
1.14%
1.34%
大文字化:
|
ボリューム (24 時間):